Recursion Pharmaceuticals, Inc. · BIVA:RXRX

Recursion Pharmaceuticals, Inc. insider trades

Recursion Pharmaceuticals, Inc.'s insiders made 0 buys and 18 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

TradeTradeSharesPriceValueDate
Borgeson Blake
Director
Sale40,000USD 3.88US$155KNov 3, 2026
Hershberg Robert
Director
Sale25,000USD 5.00US$125KOct 6, 2026
Borgeson Blake
Director
Sale50,000USD 4.84US$242KOct 6, 2026
Khan Najat
Director, Officer: CEO and President
Sale22,408USD 3.52US$78,876Sep 8, 2026
Borgeson Blake
Director
Sale30,000USD 3.34US$100KSep 1, 2026
Borgeson Blake
Director
Sale30,000USD 3.25US$97,500Aug 4, 2026
Borgeson Blake
Director
Sale40,000USD 3.96US$158KJul 7, 2026
Bumpus Namandje
Director
Sale3,963USD 3.18US$12,602Jun 18, 2026
Gibson Christopher
Director
Sale40,000USD 3.62US$145KJun 5, 2026
Khan Najat
Director, Officer: CEO and President
Sale23,588USD 3.58US$84,445Jun 5, 2026
Bumpus Namandje
Director
Sale4,386USD 3.54US$15,526Jun 3, 2026
Borgeson Blake
Director
Sale30,000USD 3.68US$110KJun 2, 2026
Gibson Christopher
Director
Sale40,000USD 3.08US$123KMay 22, 2026
Gibson Christopher
Director
Sale40,000USD 3.37US$135KMay 7, 2026
Borgeson Blake
Director
Sale30,000USD 3.52US$106KMay 5, 2026
Gibson Christopher
Director
Sale40,000USD 3.61US$144KApr 22, 2026
Borgeson Blake
Director
Sale30,000USD 3.10US$93,000Apr 7, 2026
Gibson Christopher
Director
Sale40,000USD 3.10US$124KApr 7, 2026

Recursion Pharmaceuticals, Inc. shareholders